parkhouse surgical limited Company Information
Company Number
06824692
Website
-Registered Address
2 st marys road, tonbridge, kent, TN9 2LB
Industry
Specialist medical practice activities
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Directors
Nicholas Parkhouse Dm Mch Frcs15 Years
Shareholders
nicholas parkhouse 70%
emma parkhouse 10%
View Allparkhouse surgical limited Estimated Valuation
Pomanda estimates the enterprise value of PARKHOUSE SURGICAL LIMITED at £202.9k based on a Turnover of £446k and 0.46x industry multiple (adjusted for size and gross margin).
parkhouse surgical limited Estimated Valuation
Pomanda estimates the enterprise value of PARKHOUSE SURGICAL LIMITED at £0 based on an EBITDA of £-559 and a 3.47x industry multiple (adjusted for size and gross margin).
parkhouse surgical limited Estimated Valuation
Pomanda estimates the enterprise value of PARKHOUSE SURGICAL LIMITED at £290.4k based on Net Assets of £117.3k and 2.48x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Parkhouse Surgical Limited Overview
Parkhouse Surgical Limited is a live company located in kent, TN9 2LB with a Companies House number of 06824692. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in February 2009, it's largest shareholder is nicholas parkhouse with a 70% stake. Parkhouse Surgical Limited is a established, micro sized company, Pomanda has estimated its turnover at £446k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Parkhouse Surgical Limited Health Check
Pomanda's financial health check has awarded Parkhouse Surgical Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £446k, make it in line with the average company (£517.8k)
- Parkhouse Surgical Limited
£517.8k - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (5.4%)
- Parkhouse Surgical Limited
5.4% - Industry AVG
Production
with a gross margin of 31.6%, this company has a higher cost of product (55.4%)
- Parkhouse Surgical Limited
55.4% - Industry AVG
Profitability
an operating margin of -0.1% make it less profitable than the average company (14.3%)
- Parkhouse Surgical Limited
14.3% - Industry AVG
Employees
with 4 employees, this is below the industry average (13)
- Parkhouse Surgical Limited
13 - Industry AVG
Pay Structure
on an average salary of £29.5k, the company has an equivalent pay structure (£29.5k)
- Parkhouse Surgical Limited
£29.5k - Industry AVG
Efficiency
resulting in sales per employee of £111.5k, this is more efficient (£69.2k)
- Parkhouse Surgical Limited
£69.2k - Industry AVG
Debtor Days
it gets paid by customers after 97 days, this is later than average (30 days)
- Parkhouse Surgical Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 2 days, this is quicker than average (39 days)
- Parkhouse Surgical Limited
39 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Parkhouse Surgical Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Parkhouse Surgical Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.5%, this is a lower level of debt than the average (30.8%)
1.5% - Parkhouse Surgical Limited
30.8% - Industry AVG
PARKHOUSE SURGICAL LIMITED financials
Parkhouse Surgical Limited's latest turnover from March 2023 is estimated at £446 thousand and the company has net assets of £117.3 thousand. According to their latest financial statements, we estimate that Parkhouse Surgical Limited has 4 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 112,070 | |||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | 99,647 | |||||||||||||
Interest Payable | 0 | |||||||||||||
Interest Receivable | 0 | |||||||||||||
Pre-Tax Profit | 99,647 | |||||||||||||
Tax | -22,052 | |||||||||||||
Profit After Tax | 77,595 | |||||||||||||
Dividends Paid | 0 | |||||||||||||
Retained Profit | 77,595 | |||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | ||||||||||||||
EBITDA* | 105,012 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42,921 | 96,572 | 246,795 | 252,160 | 257,525 | 262,890 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42,921 | 96,572 | 246,795 | 252,160 | 257,525 | 262,890 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 119,096 | 119,655 | 120,160 | 126,112 | 127,444 | 124,847 | 125,521 | 78,926 | 68,151 | 95,338 | 57,398 | 61,273 | 50,271 | 48,578 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,620 | 1,620 | 1,620 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 173,042 | 99,580 | 145,060 | 52,963 | 135,397 | 145,913 | 68,465 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 119,096 | 119,655 | 120,160 | 126,112 | 127,444 | 124,847 | 125,521 | 251,968 | 167,731 | 240,398 | 110,361 | 198,290 | 197,804 | 118,663 |
total assets | 119,096 | 119,655 | 120,160 | 126,112 | 127,444 | 124,847 | 125,521 | 251,968 | 210,652 | 336,970 | 357,156 | 450,450 | 455,329 | 381,553 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 1,770 | 1,770 | 1,520 | 6,332 | 6,396 | 2,412 | 1,692 | 66,257 | 49,193 | 78,744 | 51,169 | 59,501 | 283 | 2,175 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 235,486 | 301,683 |
total current liabilities | 1,770 | 1,770 | 1,520 | 6,332 | 6,396 | 2,412 | 1,692 | 66,257 | 49,193 | 78,744 | 51,169 | 59,501 | 235,769 | 303,858 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 1,770 | 1,770 | 1,520 | 6,332 | 6,396 | 2,412 | 1,692 | 66,257 | 49,193 | 78,744 | 51,169 | 59,501 | 235,769 | 303,858 |
net assets | 117,326 | 117,885 | 118,640 | 119,780 | 121,048 | 122,435 | 123,829 | 185,711 | 161,459 | 258,226 | 305,987 | 390,949 | 219,560 | 77,695 |
total shareholders funds | 117,326 | 117,885 | 118,640 | 119,780 | 121,048 | 122,435 | 123,829 | 185,711 | 161,459 | 258,226 | 305,987 | 390,949 | 219,560 | 77,695 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 99,647 | |||||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,365 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42,921 | 53,651 | 53,651 | 5,365 | 5,365 | 5,365 | 0 |
Tax | -22,052 | |||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -559 | -505 | -5,952 | -1,332 | 2,597 | -674 | 46,595 | 10,775 | -27,187 | 37,940 | -5,495 | 11,002 | 1,693 | 50,198 |
Creditors | 0 | 250 | -4,812 | -64 | 3,984 | 720 | -64,565 | 17,064 | -29,551 | 27,575 | -8,332 | 59,218 | -1,892 | 2,175 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -235,486 | -66,197 | 301,683 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | 336,620 | |||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | 0 | |||||||||||||
cash flow from financing | 100 | |||||||||||||
cash and cash equivalents | ||||||||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | -173,042 | 73,462 | -45,480 | 92,097 | -82,434 | -10,516 | 77,448 | 68,465 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -173,042 | 73,462 | -45,480 | 92,097 | -82,434 | -10,516 | 77,448 | 68,465 |
parkhouse surgical limited Credit Report and Business Information
Parkhouse Surgical Limited Competitor Analysis
Perform a competitor analysis for parkhouse surgical limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in TN9 area or any other competitors across 12 key performance metrics.
parkhouse surgical limited Ownership
PARKHOUSE SURGICAL LIMITED group structure
Parkhouse Surgical Limited has no subsidiary companies.
Ultimate parent company
PARKHOUSE SURGICAL LIMITED
06824692
parkhouse surgical limited directors
Parkhouse Surgical Limited currently has 1 director, Mr Nicholas Parkhouse Dm Mch Frcs serving since Feb 2009.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Nicholas Parkhouse Dm Mch Frcs | 67 years | Feb 2009 | - | Director |
P&L
March 2023turnover
446k
+25%
operating profit
-559
0%
gross margin
31.6%
-9.86%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
117.3k
0%
total assets
119.1k
0%
cash
0
0%
net assets
Total assets minus all liabilities
parkhouse surgical limited company details
company number
06824692
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
February 2009
age
15
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
-
address
2 st marys road, tonbridge, kent, TN9 2LB
Bank
-
Legal Advisor
-
parkhouse surgical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to parkhouse surgical limited.
parkhouse surgical limited Companies House Filings - See Documents
date | description | view/download |
---|